XENO TRANSPLANTS CORPORATION Inactive Instrument
Xeno Transplants Corporation Stock Other OTC
Equities
XENO
US98410N1072
Biotechnology & Medical Research
Financials (USD)
| Sales 2006 | - | Sales 2007 | - | Capitalization | 48.08M |
|---|---|---|---|---|---|
| Net income 2006 | - | Net income 2007 | - | EV / Sales 2006 * | - |
| Net Debt 2006 | 29.04K | Net cash position 2007 | 10.54K | EV / Sales 2007 | - |
| P/E ratio 2006 * |
-
| P/E ratio 2007 |
-
| Employees | - |
| Yield 2006 * |
-
| Yield 2007 |
-
| Free-Float | 77.05% |
More Fundamentals
* Assessed data
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 63 | 07-02-01 |
Xeno Transplants Corporation, formerly Icon Development, Inc., is a bio-technology research and development company that holds an exclusive commercial license from Massachusetts General Hospital derived from over 15 years of development in the field of xenotransplantation by Novartis Pharmaceuticals and its associated research entities. The Company intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.42% | 41.35B | |
| +42.15% | 40.38B | |
| +1.97% | 39.05B | |
| -14.19% | 26.67B | |
| +1.82% | 24.07B | |
| -24.55% | 18.36B | |
| -4.07% | 11.68B | |
| +21.36% | 11.6B | |
| +8.20% | 11.15B |
